Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2002 Jun;70(6):3300–3303. doi: 10.1128/IAI.70.6.3300-3303.2002

DNA Microarray Assessment of Putative Borrelia burgdorferi Lipoprotein Genes

Fang Ting Liang 1, F Kenneth Nelson 2, Erol Fikrig 1,*
PMCID: PMC128019  PMID: 12011030

Abstract

A DNA microarray containing fragments of 137 Borrelia burgdorferi B31 putative lipoprotein genes was used to examine Lyme disease spirochetes. DNA from B. burgdorferi sensu stricto B31, 297, and N40; Borrelia garinii IP90; and Borrelia afzelii P/Gau was fluorescently labeled and hybridized to the microarray, demonstrating the degree to which the individual putative lipoprotein genes were conserved among the genospecies. These data show that a DNA microarray can globally examine the genes encoding B. burgdorferi lipoproteins.


Lyme disease is caused by genetically diverse spirochetes collectively termed Borrelia burgdorferi sensu lato. This complex includes several genospecies, of which at least three cause significant disease in humans: B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii (17, 23). All North American pathogenic strains that have been identified are B. burgdorferi sensu stricto. In Europe, all three genospecies are found, with B. garinii and B. afzelii being the most prevalent. Manifestations of Lyme disease vary geographically, depending in part on the predominant genospecies. Lymphocytoma, acrodermatitis chronica atrophicans, and encephalomyelitis are mainly found in Europe, whereas disseminated early infection and arthritis are more common in the United States (1, 22, 25). B. burgdorferi sensu stricto strain B31 has a genome consisting of a linear chromosome and 21 linear and circular plasmids, which carries approximately 1,700 open reading frames (ORFs) (4, 7). Approximately 150 ORFs encode putative lipoproteins, more than any other known bacterium (4, 7). Nineteen of these putative lipoproteins have homologues that have been already identified in other organisms (7). Some of the remaining lipoproteins have demonstrated roles in B. burgdorferi pathogenesis, including enabling the spirochetes to adhere to decorin (8, 21), fibronectin (5, 6, 18, 19), or the tick midgut (14, 15) or to evade the immune system (26) or complement (12).

Putative lipoprotein gene DNA microarray.

To efficiently study the putative lipoprotein genes among B. burgdorferi isolates, a lipoprotein DNA microarray was developed. B. burgdorferi B31 clone 5A11, which contains all 21 known plasmids (20), was grown to the stationary phase in Barbour-Stoenner-Kelly H medium at 33°C. The spirochetes were isolated, and DNA was purified by using the DNeasy Mini kit (Qiagen Inc., Valencia, Calif.). The genomic sequence of B. burgdorferi B31 was downloaded from The Institute for Genomic Research website (http://www.tigr.org), and 137 pairs of primers were designed to amplify a 150- to 500-bp internal fragment of each lipoprotein gene. As a control, flaB primers were also designed. Since some gene families share sequence identity, it is not possible to individually differentiate these genes by hybridization. For example, the rev family consists of three members (bbc10, bbm27, and bbp27) and two of them are almost identical (bbm27 and bbp27) (4, 7). Therefore, two pairs of primers were designed for this family. One pair was unique for bbc10 while the second pair was specific for both bbm27 and bbp27. Similarly, only two pairs of primers were used for the eight members of the mlp family. Each pair only amplified one of the eight ORFs. All PCR primer sequences are available by request. PCR products were assessed by agarose gel electrophoresis, and all showed the expected sizes. Amplified DNA was purified, dissolved to a concentration of 0.05 μg/μl in 50% dimethyl sulfoxide, and spotted in triplicate on CMT-GAPS aminosilane-coated slides (Corning Inc., Corning, N.Y.) by using a Virtek SDDC-2 Arrayer (Toronto, Canada). To cross-link DNA to the microarray, printed slides were treated with 200 mJ of UV. The array was then blocked in 25% formamide plus 5× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) plus 0.1% sodium dodecyl sulfate (SDS) plus 1% bovine serum albumin at 42°C for 45 min, washed with distilled water at room temperature, and spun dry at 500 × g for 3 min.

Probe DNA was purified from cultured B. burgdorferi sensu stricto B31, 297, and N40; B. garinii IP90; and B. afzelii P/Gau or from murine spleens (control). Aminoallyl dUTP (Molecular Probes, Inc., Eugene, Oreg.) was incorporated by nick translation, fluorescently labeled with the Alexa Fluor 546 kit (B31 DNA) or the Alexa Fluor 647 kit (mouse, 297, N40, IP90, and P/Gau DNA) from Molecular Probes, purified, and lyophilized. A pair of fluorescently labeled DNA probes (one was B31 and the other was mouse, 297, N40, IP90, or P/Gau DNA) plus 10 μg of blocking mouse DNA (MboI digested) were dissolved in 15 μl of hybridization buffer (25% formamide, 5× SSC, and 0.1% SDS) and denatured at 95°C for 5 min. The heated samples were centrifuged at 8,000 × g for 2 min and applied to a preblocked microarray. The slide was covered with a coverslip and incubated in a humid chamber at 42°C for 16 to 20 h. The hybridized slide was stringently washed in hybridization buffer for 3 min and then in 2× SSC plus 0.1% SDS for an additional 3 min at 42°C. The slide was transferred into 0.2× SSC plus 0.1% SDS for 3 min, into 0.2× SCC for 1 min, and into 100% ethanol for 30 s at room temperature and spun dry. The hybridized microarray was scanned with an Axon GenePix 4000A array scanner, and raw data were captured with GenePix 3.0 software (Axon Instruments, Foster City, Calif.).

Specificity and normalization of microarray hybridization.

To determine hybridization specificity, labeled murine (control) and B31 spirochetal DNAs were allowed to bind to the microarray. The ratios of 635-nm (murine DNA) and 532-nm (B31 DNA) emission values for each spot on the microarray were <0.2; therefore, readings below this value were considered to be insignificant. Normalization was achieved by adjusting both channels of laser intensity to reach a ratio of approximately 1 when the 635- and 532-nm emission values of flaB, a highly conserved B. burgdorferi gene, were used as calibration standards for each individual microarray. The degree of conservation was determined with DNA probes from B31 and one test strain (297, N40, IP90, or P/Gau) hybridized to each spot on the microarray and was calculated as a ratio of the 635- and 532-nm emission values. The values ranged from 0 to approximately 1.0. When the ratio obtained with two hybridized DNA probes was >0.8, 0.6 to 0.79, 0.4 to 0.59, 0.2 to 0.39, or <0.2, the gene was defined as highly conserved, conserved, less conserved, may exist, or may not exist, respectively. Three separate experiments demonstrated that the microarray data were highly reproducible.

Assessment of putative lipoprotein genes among B. burgdorferi genospecies.

There are 19 lipoproteins that have homologues whose functions have been identified in other organisms (7). All of these genes were highly conserved in the American strains (Table 1). Sixteen of the genes were highly conserved in the European strain IP90. Although only 10 of the 19 genes were highly conserved in B. afzelii P/Gau, this strain shared all of these 19 genes. These genes were generally more conserved in the respective strains than were their counterparts that are unique to B. burgdorferi, regardless of whether they were located on the chromosome or on a plasmid of the spirochetes.

TABLE 1.

Conservation of putative lipoprotein genes that have homologues in other organisms

Gene Potential function Conservation in straina:
B. burgdorferi
B. garinii IP90 B. afzelii P/Gau
297 N40
bb0088 GTP-binding protein HC HC HC HC
bb0098 DNA mismatch repair protein HC HC HC LC
bb0100 Glutamate racemase HC HC HC HC
bb0122 Translation elongation factor TS HC HC HC HC
bb0141 Membrane fusion protein HC HC HC HC
bb0300 Cell division protein HC HC HC HC
bb0341 Glu-tRNA amidotransferase, subunit B HC HC HC C
bb0372 Glutamyl-tRNA synthetase HC HC C C
bb0387 Ribosomal protein S12 HC HC HC C
bb0489 Ribosomal protein L24 HC HC HC HC
bb0536 Zinc protease HC HC HC HC
bb0620 β-Glucosidase HC HC HC C
bb0621 4-Methyl-5(β-hydroxyethyl)- thiazole monophosphate biosynthesis protein HC HC LC C
bb0652 Protein export membrane protein HC HC HC HC
bb0687 Phosphomevalonate kinase HC HC C C
bb0785 Stage V sporulation protein G HC HC HC HC
bb0828 DNA topoisomerase HC HC HC HC
bba34 Oligopeptide ABC transporter HC HC HC M
bbb16 Oligopeptide ABC transporter HC HC HC LC
a

HC, highly conserved; C, conserved; LC, less conserved; M, may exist.

Of the 137 putative lipoprotein genes investigated in this study, 62 are located on the chromosome. Like B31, American strains 297 and N40 and European isolate IP90 had all 62 of these genes. These genes were highly conserved in the American strains except for two genes, bb0424 and bb0844, in strain N40 (Tables 1 and 2). Most of the 62 genes were also highly conserved in European strain IP90. The second European strain, P/Gau, might lack 3 of the 62 genes (bb0224, bb0321, and bb0424). Interestingly, these were 3 of the 5 least conserved genes (bb0224, bb0321, bb0424, bb0806, and bb0844) in strain IP90. The fourth least conserved gene was bb0844, which also was the least conserved in strain N40 (Table 2).

TABLE 2.

Conservation of putative chromosomal lipoprotein genes

Gene Conservation in straina:
B. burgdorferi
B. garinii IP90 B. afzelii P/Gau
297 N40
bb0003 HC HC HC C
bb0028 HC HC HC C
bb0038 HC HC HC LC
bb0070 HC HC HC HC
bb0071 HC HC HC C
bb0142 HC HC HC HC
bb0155 HC HC HC C
bb0185 HC HC HC HC
bb0213 HC HC C LC
bb0224 HC HC LC N
bb0227 HC HC HC C
bb0298 HC HC HC HC
bb0309 HC HC HC HC
bb0321 HC HC LC N
bb0324 HC HC C C
bb0352 HC HC HC LC
bb0365 HC HC C C
bb0382 HC HC HC C
bb0383 HC HC C HC
bb0384 HC HC HC C
bb0385 HC HC HC HC
bb0398 HC HC C M
bb0424 HC C M N
bb0458 HC HC HC C
bb0464 HC HC HC HC
bb0475 HC HC C C
bb0524 HC HC HC C
bb0542 HC HC C LC
bb0553 HC HC HC HC
bb0606 HC HC C HC
bb0628 HC HC HC HC
bb0644 HC HC HC HC
bb0664 HC HC HC LC
bb0689 HC HC HC C
bb0696 HC HC HC HC
bb0740 HC HC HC LC
bb0758 HC HC C C
bb0760 HC HC HC HC
bb0806 HC HC LC LC
bb0813 HC HC C C
bb0815 HC HC HC LC
bb0823 HC HC HC HC
bb0832 HC HC C LC
bb0840 HC HC HC LC
bb0844 HC M LC M
a

HC, highly conserved; C, conserved; LC, less conserved; M, may exist; N, may not exist.

Seventy-five putative lipoprotein genes, located on B. burgdorferi B31 plasmids, were also included in this study. Strain 297 had all of the genes, while N40 and IP90 lacked 4 (bbc10, bbf20, bbh18, and bbh32) and 2 (bbc10 and bbh32) of these 75 genes, respectively (Tables 1 and 3). Most of these genes were highly conserved in strains 297 and N40 but less conserved in IP90. B. afzelii P/Gau shared approximately 30 of these 75 genes, and most of them were not conserved.

TABLE 3.

Conservation of putative plasmid lipoprotein genes

Gene Conservation in straina:
Gene Conservation in straina:
B. burgdorferi
B. garinii IP90 B. afzelii P/Gau B. burgdorferi
B. garinii IP90 B. afzelii P/Gau
297 N40 297 N40
bba04 HC HC LC M
bb05 HC HC C M
bb07 HC HC HC M
bb14 HC HC HC LC
bb15 HC HC C M
bb16 HC HC LC N
bb24 HC HC M N
bb25 HC HC LC N
bb33 HC HC LC M
bb36 HC HC C M
bb57 HC HC C M
bb59 HC HC LC N
bb60 HC HC LC M
bb62 HC HC LC N
bb64 HC HC LC N
bb65 HC HC LC M
bb66 HC HC LC N
bb73 HC HC M N
bbb08 HC HC C M
bbb09 HC HC HC LC
bbb14 HC HC C M
bbb19 LC LC C M
bbb27 HC HC C M
bbc10 LC N N N
bbd10 HC HC HC LC
bbd24 HC C C M
bbe06 HC C LC N
bbe08 LC HC LC N
bbe09 HC HC LC N
bbe28 M HC M N
bbe31 HC HC M N
bbf20 HC N HC M
bbf32 M M C M
bbg-02 HC HC M N
bbg25 LC HC HC M
bbh01 HC M M N
bbh18 HC N M N
bbh32 HC N N N
bbi16 HC HC M N
bbi28 HC HC M N
bbi29 HC HC LC N
bbi32 HC HC LC N
bbi34 HC HC M N
bbi42 HC C M M
bbj01 HC HC LC M
bbj09 M C HC N
bbj34 LC C LC N
bbj36 M C HC N
bbj51 M C M N
bbk04 HC LC C C
bbk07 HC HC M N
bbk12 HC HC M N
bbk19 HC C LC N
bbk32 HC HC HC N
bbk47 M HC M N
bbk49 M C M N
bbk53 HC LC LC M
bbl39 C C C N
bbl40 HC LC M N
bbm27 LC HC M N
bbm38 LC LC C N
bbn38 LC C LC N
bbn39 HC C M N
bbo39 HC HC LC M
bbo40 C C M N
bbp38 HC HC HC N
bbq03 HC LC C C
bbq05 C M M N
bbq35 HC LC M N
bbq47 M LC M N
bbr42 HC HC LC M
bbs30 HC HC LC N
bbs41 LC LC C M
a

HC, highly conserved; C, conserved; LC, less conserved; M, may exist; N, may not exist.

B. burgdorferi B31 contains 21 linear and circular plasmids, 19 of which carry at least one putative lipoprotein gene, including plasmids A (lp54), B (cp26), C (cp9), D (lp17), E (lp25), F (lp28-1), G (lp28-2), H (lp28-3), I (lp28-4), J (lp38), K (lp36), L (cp32-8), M (cp32-6), N (cp32-9), O (cp32-7), P (cp32-1), Q (lp56), R (cp32-4), and S (cp32-3) (4, 7). Linear plasmids T (lp5) and U (lp21) do not carry any suspected lipoprotein genes. The DNA microarrays contained gene fragments amplified from these 19 lipoprotein gene-carrying plasmids. Examination of bbc10, the only suspected lipoprotein gene on cp9, would suggest that N40 and IP90 may lack this plasmid (Table 3). Lack of conservation of this gene in strains N40 and IP90 or loss of the cp9 plasmid during in vitro cultivation might, however, also explain the low ratios of bound DNA probes of these two strains (3). In contrast, lp54 contains 19 lipoprotein genes. Therefore, it is more likely that the detection or absence of these genes in the DNA microarray would reflect the presence or lack of this plasmid. Palmer and colleagues studied the distribution of linear plasmids with a set of different markers and suggested that strains N40, IP90, and P/Gau lack lp56 (16). In B. burgdorferi B31, this plasmid contains 4 lipoprotein genes, bbq03, bbq05, bbq35, and bbq47 (4, 7), all of which can be detected in both N40 and IP90 with our microarray (Table 3). Plasmid gene arrangements among spirochetes could potentially account for these differences. For example, vlsE is carried by lp28-1 in strain B31 (26) but may be located on a different size plasmid in other isolates (13, 24). When vlsE was used as the marker for lp28-1, our studies indicated that both IP90 and P/Gau contained this plasmid, in contrast to Palmer and colleagues' result that both isolates lack lp28-1 (16). Therefore, the complete sequencing of individual plasmids is the only valid method of determining which lipoprotein genes are present on specific plasmids.

The B. burgdorferi B31 genome has 17 chromosomal lipoproteins with homologues whose functions have been defined in other organisms (7), and our data suggest that these genes were very conserved in the spirochetes tested. In addition, bba15 (ospA, which facilitates tick attachment) (14, 15), bbb19 (ospC) (2), and bbf32 (vslE, involved in immune evasion) (26) may play important roles in the B. burgdorferi enzootic life cycle and are generally detectable in all of the genospecies. Plasmid loss might partially explain why the extrachromosomal genes were less conserved and few plasmid genes were detected in isolate P/Gau. However, these data on the chromosomal genes should not be affected by this phenomenon. In fact, our studies strongly indicated that most of the chromosomal lipoprotein genes were significantly less conserved in B. afzelii P/Gau than other strains, including the European isolate IP90. This may provide a reasonable explanation for the observations reported by other researchers that antigenic proteins are highly divergent among European isolates (9-11).

We have developed a DNA microarray to examine 137 lipoprotein genes of five B. burgdorferi isolates. Our results suggest that the DNA microarray can be used globally to examine the putative lipoprotein genes among B. burgdorferi isolates, including the three major B. burgdorferi sensu lato genospecies, B. burgdorferi sensu stricto, B. garinii, and B. afzelii. The B. burgdorferi lipoprotein gene microarray should prove useful in the genetic studies of geographic collections of B. burgdorferi, the examination of B. burgdorferi lipoprotein gene expression under different in vitro conditions, and the expression of B. burgdorferi lipoproteins throughout the B. burgdorferi life cycle in the arthropod vector and the mammalian host.

Acknowledgments

We thank Steven Norris (University of Texas, Houston) for providing clonal isolate B31 5A11.

This study was supported by grants from the National Institutes of Health and the American Heart Association. E.F. is the recipient of a Burroughs Wellcome Clinical Scientist Award in Translational Research.

Editor: D. L. Burns

REFERENCES

  • 1.Ackermann, R., P. Hörstrup, and R. Schmidt. 1984. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J. Biol. Med. 57:485-490. [PMC free article] [PubMed] [Google Scholar]
  • 2.Baranton, G., G. Seinost, G. Theodore, D. Postic, and D. Dykhuizen. 2001. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res. Microbiol. 152:149-156. [DOI] [PubMed] [Google Scholar]
  • 3.Barbour, A. G. 1988. Plasmid analysis of Borrelia burgdorferi, the Lyme disease spirochete. J. Clin. Microbiol. 26:475-478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Casjens, S., N. Palmer, R. V. Vugt, W. M. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. M. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516. [DOI] [PubMed] [Google Scholar]
  • 5.Fikrig, E., S. W. Barthold, W. Sun, W. Feng, S. R. Telford III, and R. A. Flavell. 1997. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity 6:531-539. [DOI] [PubMed] [Google Scholar]
  • 6.Fikrig, E., W. Feng, S. W. Barthold, S. R. Telford III, and R. A. Flavell. 2000. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J. Immunol. 164:5344-5351. [DOI] [PubMed] [Google Scholar]
  • 7.Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickery, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Saizberg, M. Hanson, R. V. Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochete, Borrelia burgdorferi. Nature 390:580-586. [DOI] [PubMed] [Google Scholar]
  • 8.Gao, B. P., S. J. Norris, L. C. Rosenberg, and M. Höök. 1995. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63:3467-3472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hauser, U., G. Lehnert, R. Lobentanzer, and B. Wilske. 1997. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 35:1433-1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hauser, U., G. Lehnert, and B. Wilske. 1999. Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J. Clin. Microbiol. 37:2241-2247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hauser, U., H. Krahl, H. Peters, V. Fingerle, and B. Wilske. 1998. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 36:427-436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hellwage, J., T. Meri, T. Heikkilä, A. Alitalo, J. Panelius, P. Lahdenne, I. J. T. Seppälä, and S. Meri. 2001. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276:8427-8435. [DOI] [PubMed] [Google Scholar]
  • 13.Kawabata, H., F. Myouga, Y. Inagaki, N. Murai, and H. Watanabe. 1998. Genetic and immunological analyses of Vls (VMP-like sequences) of Borrelia burgdorferi. Microb. Pathog. 24:155-166. [DOI] [PubMed] [Google Scholar]
  • 14.Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet, and E. Fikrig. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Investig. 106:561-569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pal, U., R. R. Montgomery, D. Lusitani, P. Voet, V. Wevnanys, S. E. Malawista, Y. Lobet, and E. Fikrig. 2001. Inhibition of Borrelia burgdorferi-tick interaction in vivo by outer surface protein A antibody. J. Immunol. 166:7398-7403. [DOI] [PubMed] [Google Scholar]
  • 16.Palmer, N., C. Fraser, and S. Casjens. 2000. Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes. J. Bacteriol. 182:2476-2480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Postic, D., M. V. Assous, P. A. Grimont, and G. Baranton. 1994. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons. Int. J. Syst. Bacteriol. 44:743-752. [DOI] [PubMed] [Google Scholar]
  • 18.Probert, W. S., and B. J. B. Johnson. 1998. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi B31. Mol. Microbiol. 30:1003-1015. [DOI] [PubMed] [Google Scholar]
  • 19.Probert, W. S., J. H. Kim, M. Höök, and B. J. B. Johnson. 2001. Mapping the ligand region of Borrelia burgdorferi fibronectin-binding protein BBK32. Infect. Immun. 69:4129-4133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Purser, J. E., and S. J. Norris. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 97:13865-13870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Roberts, W. C., B. A. Mullikin, R. Lathigra, and M. S. Hanson. 1998. Molecular analysis of sequence heterogeneity among genes encoding decorin binding protein A and B of Borrelia burgdorferi sensu lato. Infect. Immun. 66:5275-5285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Steere, A. C., N. H. Bartenhagen, J. G. Craft, G. J. Newman, D. W. Rahn, L. H. Sigal, P. N. Spieler, K. S. Stenn, and S. E. Malawista. 1983. The early clinical manifestations of Lyme disease. Ann. Intern. Med. 99:76-82. [DOI] [PubMed] [Google Scholar]
  • 23.Wang, G., A. van Dam, I. Schwartz, and J. Dankert. 1999. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev. 12:633-653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang, G., A. van Dam, and J. Dankert. 2001. Analysis of a VMP-like sequence (vls) locus in Borrelia garinii and Vls homologues among four Borrelia burgdorferi sensu lato species. FEMS Microbiol. Lett. 15:39-45. [DOI] [PubMed] [Google Scholar]
  • 25.Weber, K., G. Schierz, B. Wilske, and V. Preac-Mursic. 1984. European erythema migrans disease and related disorders. Yale J. Biol. Med. 57:13-21. [PMC free article] [PubMed] [Google Scholar]
  • 26.Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease Borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES